USA Financial Formulas bought a new stake in Exponent, Inc. (NASDAQ:EXPO – Free Report) in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm bought 522 shares of the business services provider’s stock, valued at approximately $60,000.
Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. GAMMA Investing LLC grew its stake in Exponent by 64.6% in the third quarter. GAMMA Investing LLC now owns 624 shares of the business services provider’s stock valued at $72,000 after acquiring an additional 245 shares during the period. Handelsbanken Fonder AB grew its position in Exponent by 27.7% in the 3rd quarter. Handelsbanken Fonder AB now owns 12,900 shares of the business services provider’s stock valued at $1,487,000 after purchasing an additional 2,800 shares during the period. Curbstone Financial Management Corp bought a new stake in Exponent during the 3rd quarter valued at $445,000. Cubist Systematic Strategies LLC acquired a new position in Exponent during the second quarter worth $293,000. Finally, Point72 Asia Singapore Pte. Ltd. bought a new position in shares of Exponent in the second quarter valued at $146,000. 92.37% of the stock is owned by institutional investors.
Exponent Stock Down 2.2 %
Shares of NASDAQ:EXPO opened at $110.70 on Friday. The business’s 50 day moving average is $107.58 and its 200 day moving average is $97.79. Exponent, Inc. has a 12-month low of $64.61 and a 12-month high of $115.61. The stock has a market cap of $5.61 billion, a price-to-earnings ratio of 55.91 and a beta of 0.66.
Exponent Dividend Announcement
The firm also recently announced a quarterly dividend, which was paid on Friday, September 20th. Stockholders of record on Friday, September 6th were paid a $0.28 dividend. The ex-dividend date of this dividend was Friday, September 6th. This represents a $1.12 dividend on an annualized basis and a dividend yield of 1.01%. Exponent’s payout ratio is presently 56.57%.
Insider Activity
In other Exponent news, VP John Pye sold 3,956 shares of the business’s stock in a transaction on Tuesday, July 30th. The stock was sold at an average price of $105.00, for a total value of $415,380.00. Following the transaction, the vice president now owns 28,422 shares of the company’s stock, valued at approximately $2,984,310. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 2.10% of the stock is currently owned by corporate insiders.
Analyst Upgrades and Downgrades
Separately, Truist Financial reissued a “buy” rating and set a $120.00 target price (up from $100.00) on shares of Exponent in a research report on Friday, July 26th.
Get Our Latest Stock Analysis on EXPO
Exponent Profile
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.
See Also
- Five stocks we like better than Exponent
- What is a Death Cross in Stocks?
- MercadoLibre Targets Double-Digit Upside with Argentina Boom
- Want to Profit on the Downtrend? Downtrends, Explained.
- Domino’s Pizza Stock Delivers: A Hot Buy for Growth Investors
- How Technical Indicators Can Help You Find Oversold Stocks
- 3 Small-Cap Stocks Ready to Deliver Significant Growth
Want to see what other hedge funds are holding EXPO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Exponent, Inc. (NASDAQ:EXPO – Free Report).
Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.